SCHEMBL3096310

SCHEMBL3096310

CN(C(=O)c1ccccc1)c1cccnc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.45
LMNA P02545 2/20 0.45
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
TP53 P04637 1/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
HSD17B10 Q99714 2/20 0.41
GRM1 Q13255 2/20 0.41
GPBAR1 Q8TDU6 5/20 0.41
ACLY P53396 1/20 0.40
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15204972 0.83 SMN1; SMN2 (0.50) KDM4EKMT2ASMN1; SMN2LMNARAB9A
SCHEMBL8301115 0.83 LMNA (0.54) KMT2ASMN1; SMN2LMNANPC1CYP1A2
SCHEMBL9001643 0.79 KMT2A (0.53) KDM4EKMT2ASMN1; SMN2LMNARAB9A
SCHEMBL28154646 0.79 LMNA (0.51) KDM4EKMT2ASMN1; SMN2LMNARAB9A
SCHEMBL8341101 0.79 LMNA (0.46) KMT2ASMN1; SMN2LMNAALDH1A1TP53
SCHEMBL2485282 0.79 SMN1; SMN2 (0.44) KDM4EKMT2ASMN1; SMN2LMNARAB9A
SCHEMBL28867961 0.78 GPBAR1 (0.50) KDM4EKMT2ASMN1; SMN2LMNARAB9A
SCHEMBL14507079 0.78 KMT2A (0.58) KDM4EKMT2ASMN1; SMN2LMNARAB9A
SCHEMBL3088778 0.77 GPBAR1 (0.46) KMT2ASMN1; SMN2LMNAGPBAR1
SCHEMBL15221592 0.76 KDM4E (0.43) KDM4EKMT2ASMN1; SMN2LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7799918-B2 Organic metal complexes INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2010-09-21 US disclosed
US-7799918-B2 Organic metal complexes INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2010-09-21 US disclosed
US-7799918-B2 Organic metal complexes INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2010-09-21 US disclosed
US-20080214818-A1 Organic metal complexes INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE 2008-09-04 US disclosed
US-20080214818-A1 Organic metal complexes INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE 2008-09-04 US disclosed
US-20080214818-A1 Organic metal complexes INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214818-A1 Organic metal complexes C5, C9, C1S KDM4E 2302/4885KMT2A 1902/4885SMN1; SMN2 3956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.